"The entire thought of allowing shorting stock and the resulting destruction is reprehensible."
I think the same thing is about to happen to EPIX, just 4 weeks from now. Small cap low volume name, and short interest has gone from basically zero to 12.5 days to cover in just the last few weeks. They are releasing data on monotherapy in June, likely to be "ok" with the more important combo data not for another 6 months. I feel a short attack coming like what we got in NWBO. We'll see if I'm wrong. Disclosure, owned the name since 2019, my largest position.
Difference is institutional ownership, NWBO has very little and EPIX is heavy, with PFE owning about 4% of the company. But it's pretty thinly traded imo, so subject to being screwed with?
News 
Market Data 
Discover 
